Symbols / SERA
SERA Chart
About
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 92.43M |
| Enterprise Value | 45.98M | Income | -32.63M | Sales | 95.00K |
| Book/sh | 2.13 | Cash/sh | 1.12 | Dividend Yield | — |
| Payout | 0.00% | Employees | 63 | IPO | — |
| P/E | — | Forward P/E | -3.42 | PEG | — |
| P/S | 973.00 | P/B | 1.12 | P/C | — |
| EV/EBITDA | -1.27 | EV/Sales | 484.00 | Quick Ratio | 1.84 |
| Current Ratio | 1.89 | Debt/Eq | 2.98 | LT Debt/Eq | — |
| EPS (ttm) | -0.76 | EPS next Y | -0.70 | EPS Growth | — |
| Revenue Growth | -44.80% | Earnings | 2026-03-18 | ROA | -24.70% |
| ROE | -47.69% | ROIC | — | Gross Margin | -62.10% |
| Oper. Margin | -561.25% | Profit Margin | 0.00% | Shs Outstand | 37.63M |
| Shs Float | 26.96M | Short Float | 1.04% | Short Ratio | 5.05 |
| Short Interest | — | 52W High | 4.39 | 52W Low | 1.37 |
| Beta | 0.99 | Avg Volume | 50.06K | Volume | 9.65K |
| Target Price | $5.00 | Recom | Strong_buy | Prev Close | $2.25 |
| Price | $2.40 | Change | 6.44% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$5.00
Mean price target
2. Current target
$2.40
Latest analyst target
3. DCF / Fair value
$-7.91
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.40
Low
$5.00
High
$5.00
Mean
$5.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-08-10 | main | Citigroup | Neutral → Neutral | $3 |
| 2022-11-10 | main | Citigroup | — → Neutral | $2 |
| 2022-08-29 | main | Oppenheimer | — → Outperform | $11 |
| 2022-04-27 | init | Berenberg | — → Buy | $13 |
| 2022-03-30 | down | Citigroup | Buy → Neutral | $4 |
| 2021-11-19 | init | Oppenheimer | — → Outperform | $19 |
| 2021-08-09 | init | William Blair | — → Outperform | — |
| 2021-08-09 | init | Citigroup | — → Buy | $18 |
| 2021-08-09 | init | Cowen & Co. | — → Outperform | — |
- Insider Sell: Robert Harrison Sells 2,000 Shares of Sera Prognos - GuruFocus Wed, 25 Feb 2026 02
- Sera Prognostics (NASDAQ:SERA) Stock Price Down 2.3% - Here's Why - MarketBeat Sat, 21 Feb 2026 08
- Enhabit (EHAB) Surges 22.6%: Is This an Indication of Further Gains? - Nasdaq ue, 24 Feb 2026 14
- SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS - PR Newswire hu, 13 Nov 2025 08
- Would You Still Hold Sera Prognostics Stock If It Fell 30%? - Trefis Sat, 20 Dec 2025 08
- Sera Prognostics: Few Takers For A Great Product Spells Angst (NASDAQ:SERA) - Seeking Alpha Mon, 22 Sep 2025 07
- Sera Prognostics CIO Harrison sells $5940 in stock - Investing.com ue, 27 Jan 2026 08
- With 40% ownership, Sera Prognostics, Inc. (NASDAQ:SERA) has piqued the interest of institutional investors - Yahoo Finance Sun, 28 Dec 2025 08
- Have Insiders Sold Sera Prognostics Shares Recently? - simplywall.st Sat, 13 Dec 2025 08
- Simple pregnancy blood test cuts NICU stays and earliest preterm births - Stock Titan Wed, 07 Jan 2026 08
- Sera Prognostics (NASDAQ:SERA) Shares Down 2.8% - Here's Why - MarketBeat Fri, 30 Jan 2026 08
- Japan’s $6.8 Trillion Stock Market Faces Reckoning in Elections - Bloomberg Wed, 16 Jul 2025 07
- Jefferies initiates Sera Prognostics stock with Buy rating on preterm birth test - Investing.com Mon, 15 Dec 2025 08
- Sera Prognostics (SERA) Upgraded to Buy: Here's Why - Nasdaq Wed, 26 Nov 2025 08
- We Think Sera Prognostics (NASDAQ:SERA) Needs To Drive Business Growth Carefully - simplywall.st Sat, 24 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 2000 | 5940 | — | Sale at price 2.97 per share. | HARRISON ROBERT GARDNER | Chief Technology Officer | — | 2026-01-27 00:00:00 | D |
| 1 | 2000 | 6000 | — | Sale at price 3.00 per share. | HARRISON ROBERT GARDNER | Chief Technology Officer | — | 2025-12-30 00:00:00 | D |
| 2 | 873 | 2890 | — | Sale at price 3.31 per share. | AERTS AUSTIN | Chief Financial Officer | — | 2025-12-10 00:00:00 | D |
| 3 | 616 | 2039 | — | Sale at price 3.31 per share. | HARRISON ROBERT GARDNER | Chief Technology Officer | — | 2025-12-10 00:00:00 | D |
| 4 | 892 | 2953 | — | Sale at price 3.31 per share. | JACKSON BENJAMIN R | General Counsel | — | 2025-12-10 00:00:00 | D |
| 5 | 1332 | 4409 | — | Sale at price 3.31 per share. | BONIFACE JOHN J | Officer | — | 2025-12-10 00:00:00 | D |
| 6 | 1213 | 4015 | — | Sale at price 3.31 per share. | KEARNEY PAUL | Officer | — | 2025-12-10 00:00:00 | D |
| 7 | 4155 | 13753 | — | Sale at price 3.31 per share. | LINDGARDT ZHENYA | Chief Executive Officer | — | 2025-12-10 00:00:00 | D |
| 8 | 5232 | 15905 | — | Sale at price 3.04 per share. | AERTS AUSTIN | Chief Financial Officer | — | 2025-12-09 00:00:00 | D |
| 9 | 28215 | 85774 | — | Sale at price 3.04 per share. | LINDGARDT ZHENYA | Chief Executive Officer | — | 2025-12-09 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -33.05M | -37.28M | -44.44M | -34.61M |
| TotalUnusualItems | 1.02M | 1.99M | 1.07M | 1.01M |
| TotalUnusualItemsExcludingGoodwill | 1.02M | 1.99M | 1.07M | 1.01M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -32.90M | -36.24M | -44.19M | -35.01M |
| ReconciledDepreciation | 833.00K | 900.00K | 756.00K | 659.00K |
| ReconciledCostOfRevenue | 82.00K | 210.00K | 193.00K | 37.00K |
| EBITDA | -32.04M | -35.29M | -43.37M | -33.60M |
| EBIT | -32.87M | -36.19M | -44.12M | -34.26M |
| NetInterestIncome | 2.72M | 1.58M | 395.00K | -601.00K |
| InterestExpense | 28.00K | 55.00K | 61.00K | 746.00K |
| InterestIncome | 2.75M | 1.64M | 456.00K | 145.00K |
| NormalizedIncome | -33.92M | -38.24M | -45.26M | -36.02M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -32.90M | -36.24M | -44.19M | -35.01M |
| TotalExpenses | 36.71M | 40.13M | 45.92M | 35.48M |
| TotalOperatingIncomeAsReported | -36.63M | -39.82M | -45.65M | -35.40M |
| DilutedAverageShares | 33.16M | 31.20M | 30.94M | 15.00M |
| BasicAverageShares | 33.16M | 31.20M | 30.94M | 15.00M |
| DilutedEPS | -0.99 | -1.16 | -1.43 | -2.33 |
| BasicEPS | -0.99 | -1.16 | -1.43 | -2.33 |
| DilutedNIAvailtoComStockholders | -32.90M | -36.24M | -44.19M | -35.01M |
| NetIncomeCommonStockholders | -32.90M | -36.24M | -44.19M | -35.01M |
| NetIncome | -32.90M | -36.24M | -44.19M | -35.01M |
| NetIncomeIncludingNoncontrollingInterests | -32.90M | -36.24M | -44.19M | -35.01M |
| NetIncomeContinuousOperations | -32.90M | -36.24M | -44.19M | -35.01M |
| PretaxIncome | -32.90M | -36.24M | -44.19M | -35.01M |
| OtherIncomeExpense | 1.02M | 1.99M | 1.07M | 987.00K |
| OtherNonOperatingIncomeExpenses | -20.00K | |||
| SpecialIncomeCharges | 0.00 | 1.05M | ||
| OtherSpecialCharges | -1.05M | |||
| GainOnSaleOfSecurity | 1.02M | 1.99M | 1.07M | -43.00K |
| NetNonOperatingInterestIncomeExpense | 2.72M | 1.58M | 395.00K | -601.00K |
| InterestExpenseNonOperating | 28.00K | 55.00K | 61.00K | 746.00K |
| InterestIncomeNonOperating | 2.75M | 1.64M | 456.00K | 145.00K |
| OperatingIncome | -36.63M | -39.82M | -45.65M | -35.40M |
| OperatingExpense | 36.63M | 39.92M | 45.73M | 35.44M |
| ResearchAndDevelopment | 14.73M | 15.22M | 14.24M | 11.02M |
| SellingGeneralAndAdministration | 21.90M | 24.69M | 31.48M | 24.42M |
| SellingAndMarketingExpense | 5.77M | 8.35M | 14.70M | 10.33M |
| GeneralAndAdministrativeExpense | 16.13M | 16.34M | 16.78M | 14.09M |
| OtherGandA | 16.13M | 16.34M | 16.78M | 14.09M |
| GrossProfit | -5.00K | 96.00K | 75.00K | 45.00K |
| CostOfRevenue | 82.00K | 210.00K | 193.00K | 37.00K |
| TotalRevenue | 77.00K | 306.00K | 268.00K | 82.00K |
| OperatingRevenue | 77.00K | 306.00K | 268.00K | 82.00K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 34.17M | 31.70M | 31.02M | 30.77M |
| ShareIssued | 34.17M | 31.70M | 31.02M | 30.77M |
| TotalDebt | 840.00K | 1.86M | 2.83M | 128.00K |
| TangibleBookValue | 46.78M | 70.16M | 98.94M | 138.56M |
| InvestedCapital | 47.80M | 70.16M | 98.94M | 138.56M |
| WorkingCapital | 22.83M | 36.90M | 74.59M | 101.84M |
| NetTangibleAssets | 46.78M | 70.16M | 98.94M | 138.56M |
| CapitalLeaseObligations | 840.00K | 1.86M | 2.83M | 128.00K |
| CommonStockEquity | 47.80M | 70.16M | 98.94M | 138.56M |
| TotalCapitalization | 47.80M | 70.16M | 98.94M | 138.56M |
| TotalEquityGrossMinorityInterest | 47.80M | 70.16M | 98.94M | 138.56M |
| StockholdersEquity | 47.80M | 70.16M | 98.94M | 138.56M |
| GainsLossesNotAffectingRetainedEarnings | 60.00K | -15.00K | -981.00K | -183.00K |
| OtherEquityAdjustments | 60.00K | -15.00K | -981.00K | -183.00K |
| RetainedEarnings | -279.79M | -246.90M | -210.65M | -166.47M |
| AdditionalPaidInCapital | 327.53M | 317.07M | 310.57M | 305.21M |
| CapitalStock | 3.00K | 3.00K | 3.00K | 3.00K |
| CommonStock | 3.00K | 3.00K | 3.00K | 3.00K |
| TotalLiabilitiesNetMinorityInterest | 24.77M | 25.28M | 17.39M | 8.46M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 2.00K | 840.00K | 1.85M | 54.00K |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| DerivativeProductLiabilities | 0.00 | |||
| NonCurrentDeferredLiabilities | 0.00 | |||
| LongTermDebtAndCapitalLeaseObligation | 2.00K | 840.00K | 1.85M | 54.00K |
| LongTermCapitalLeaseObligation | 2.00K | 840.00K | 1.85M | 54.00K |
| CurrentLiabilities | 24.77M | 24.44M | 15.54M | 8.41M |
| OtherCurrentLiabilities | 296.00K | 926.00K | 637.00K | 927.00K |
| CurrentDeferredLiabilities | 20.22M | 20.23M | 9.08M | 3.25M |
| CurrentDeferredRevenue | 20.22M | 20.23M | 9.08M | 3.12M |
| CurrentDebtAndCapitalLeaseObligation | 838.00K | 1.02M | 983.00K | 74.00K |
| CurrentCapitalLeaseObligation | 838.00K | 1.02M | 983.00K | 74.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 1.44M | 1.14M | 2.29M | 2.50M |
| PayablesAndAccruedExpenses | 1.97M | 1.12M | 2.55M | 1.66M |
| CurrentAccruedExpenses | 0.00 | 74.00K | 998.00K | 460.00K |
| InterestPayable | 0.00 | |||
| Payables | 1.97M | 1.05M | 1.55M | 1.20M |
| AccountsPayable | 1.97M | 1.05M | 1.55M | 1.20M |
| TotalAssets | 72.58M | 95.44M | 116.33M | 147.03M |
| TotalNonCurrentAssets | 24.98M | 34.10M | 26.20M | 36.78M |
| OtherNonCurrentAssets | 737.00K | 1.26M | 1.82M | 157.00K |
| InvestmentsAndAdvances | 21.97M | 30.84M | 21.33M | 34.85M |
| InvestmentinFinancialAssets | 21.97M | 30.84M | 21.33M | 34.85M |
| AvailableForSaleSecurities | 21.97M | 30.84M | 21.33M | 34.85M |
| GoodwillAndOtherIntangibleAssets | 1.03M | 0.00 | ||
| OtherIntangibleAssets | 1.03M | |||
| NetPPE | 1.24M | 2.00M | 3.06M | 1.77M |
| AccumulatedDepreciation | -7.76M | -7.02M | -6.26M | -5.97M |
| GrossPPE | 8.99M | 9.02M | 9.31M | 7.74M |
| Leases | 772.00K | 772.00K | 710.00K | 710.00K |
| OtherProperties | 5.66M | 5.73M | 5.91M | 5.03M |
| MachineryFurnitureEquipment | 2.56M | 2.52M | 2.69M | 2.00M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 47.60M | 61.34M | 90.12M | 110.25M |
| OtherCurrentAssets | 1.31M | 795.00K | 1.31M | 1.99M |
| PrepaidAssets | 1.99M | |||
| Receivables | 53.00K | 11.47M | 6.11M | 3.14M |
| OtherReceivables | 19.00K | 11.31M | 6.00M | 3.12M |
| AccountsReceivable | 34.00K | 160.00K | 113.00K | 27.00K |
| CashCashEquivalentsAndShortTermInvestments | 46.24M | 49.08M | 82.70M | 105.11M |
| OtherShortTermInvestments | 42.19M | 45.20M | 52.83M | 46.18M |
| CashAndCashEquivalents | 4.04M | 3.88M | 29.88M | 58.93M |
| CashEquivalents | 2.06M | 1.27M | 28.96M | 58.86M |
| CashFinancial | 1.98M | 2.61M | 913.00K | 70.00K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -15.29M | -27.32M | -35.40M | -32.94M |
| RepaymentOfDebt | -440.00K | -466.00K | -303.00K | -7.66M |
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 0.00 | 165.59M | ||
| CapitalExpenditure | -1.10M | -128.00K | -791.00K | -1.30M |
| InterestPaidSupplementalData | 28.00K | 55.00K | 48.00K | 1.19M |
| EndCashPosition | 4.04M | 3.88M | 29.88M | 58.93M |
| BeginningCashPosition | 3.88M | 29.88M | 58.93M | 13.53M |
| ChangesInCash | 163.00K | -26.00M | -29.05M | 45.40M |
| FinancingCashFlow | 2.61M | 752.00K | 5.00K | 159.59M |
| CashFlowFromContinuingFinancingActivities | 2.61M | 752.00K | 5.00K | 159.59M |
| ProceedsFromStockOptionExercised | 3.05M | 1.22M | 308.00K | 1.66M |
| NetPreferredStockIssuance | 0.00 | 98.98M | ||
| PreferredStockIssuance | 0.00 | 98.98M | ||
| NetCommonStockIssuance | 0.00 | 66.61M | ||
| CommonStockIssuance | 0.00 | 66.61M | ||
| NetIssuancePaymentsOfDebt | -440.00K | -466.00K | -303.00K | -7.66M |
| NetLongTermDebtIssuance | -440.00K | -466.00K | -303.00K | -7.66M |
| LongTermDebtPayments | -440.00K | -466.00K | -303.00K | -7.66M |
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | 11.74M | 438.00K | 5.55M | -82.56M |
| CashFlowFromContinuingInvestingActivities | 11.74M | 438.00K | 5.55M | -82.56M |
| NetInvestmentPurchaseAndSale | 12.84M | 255.00K | 6.33M | -81.25M |
| SaleOfInvestment | 48.67M | 54.40M | 54.40M | 800.00K |
| PurchaseOfInvestment | -35.83M | -54.14M | -48.07M | -82.06M |
| NetIntangiblesPurchaseAndSale | -1.04M | 0.00 | ||
| PurchaseOfIntangibles | -1.04M | 0.00 | ||
| NetPPEPurchaseAndSale | -56.00K | 183.00K | -775.00K | -1.30M |
| SaleOfPPE | 0.00 | 311.00K | 16.00K | 0.00 |
| PurchaseOfPPE | -56.00K | -128.00K | -791.00K | -1.30M |
| OperatingCashFlow | -14.19M | -27.19M | -34.61M | -31.64M |
| CashFlowFromContinuingOperatingActivities | -14.19M | -27.19M | -34.61M | -31.64M |
| ChangeInWorkingCapital | 11.28M | 3.52M | 3.55M | -44.00K |
| ChangeInOtherWorkingCapital | -12.00K | 11.15M | 5.97M | 2.99M |
| ChangeInPayablesAndAccruedExpense | -120.00K | -2.74M | -162.00K | 1.99M |
| ChangeInAccruedExpense | -575.00K | -2.30M | -514.00K | 1.39M |
| ChangeInPayable | 455.00K | -442.00K | 352.00K | 603.00K |
| ChangeInAccountPayable | 455.00K | -442.00K | 352.00K | 603.00K |
| ChangeInPrepaidAssets | -10.00K | 465.00K | 718.00K | -1.88M |
| ChangeInReceivables | 11.42M | -5.36M | -2.97M | -3.14M |
| ChangesInAccountReceivables | 126.00K | -47.00K | -86.00K | -25.00K |
| OtherNonCashItems | 498.00K | 544.00K | 452.00K | 678.00K |
| StockBasedCompensation | 7.01M | 5.27M | 5.05M | 3.13M |
| DepreciationAmortizationDepletion | 833.00K | 900.00K | 756.00K | 659.00K |
| DepreciationAndAmortization | 833.00K | 900.00K | 756.00K | 659.00K |
| OperatingGainsLosses | -910.00K | -1.18M | -239.00K | -1.05M |
| GainLossOnInvestmentSecurities | -910.00K | -1.18M | -239.00K | |
| NetIncomeFromContinuingOperations | -32.90M | -36.24M | -44.19M | -35.01M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for SERA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|